How We WorkOrder NowSupport Privacy


on 16/01/2013

Houston, TX – January 16, 2013 — (Net PR News) – delivers quality trading ideas for the elite investor that has the financial wherewithal and market nimbleness to profit on small moves in a stock’s price. Become a member and you will be provided with real-time alerts intended to provide you with the opportunity to make profitable trades. To receive our FREE, comprehensive newsletter, visit

Stocks that are being watched this morning are: DNDN, ARNA, ITMN, CELG

Dendreon Corporation (NASDAQ:DNDN) announced initial revenues for the fiscal fourth quarter. The company expects net product revenue for the quarter of almost $85.5 million which holds almost a $3.8 million favorable adjustment to the chargebacks reserve of the company due to a change in estimation.

Dendreon Corporation’s percentage change advanced 0.94% to close at $6.47 with the total traded volume of 8.27 million shares, as compared to average volume of 6.63 million shares. The Company’s lowest price during last trade was $6.30 while its highest price was $6.51 for the day.

How Should Investors Trade DNDN Now? Don’t Trade DNDN Until You Read This TREND ANALYSIS REPORT

DNDN’s total market capitalization is $998.43 million, along with 154.32 million shares outstanding. Its beta value stands at 3.89 points and its earning per shares remained $-2.13.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported an upsurge of 5.97% after opening at the price of $10.34. Its closing price for the day was $10.81.

ARNA’s total trading volume for the day was 27.97 million shares versus its average volume of 8.49 million shares. The Company’s current market capitalization stands at $2.35 billion along with 217.29 million shares.

If we look at the previous 5 day’s performance of the stock, it remained reported the gain of 20.11%, while in its last one month’s trade it surged 17.76%. Arena Pharmaceuticals’  earning per share is $-0.53 while its beta value stands at 0.24 times.

How Should Investors React To ARNA Now? Find Out In This TREND ANALYSIS REPORT

InterMune, Inc. (NASDAQ:ITMN) percentage change advanced 0.50% to close at $10.04 with the total traded volume of 5.87million shares, as compared to average volume of 1.06 million. Its market capitalization is $662.80 billion and EPS was $-2.92. ITMN’s shares were trading within the range of $9.19-$10.20 while its opening price was $9.27.

If we look at its previous three months trade, it surged 27.41%, while in the last 5 day’s it remained down-3.37%.

Get A Free Report And Detailed Analysis On ITMN CLICK HERE To Read

InterMune, Inc. (NASDAQ:ITMN) has planned to offer 12.5 million shares of its common stock in contemporary backed public offerings. The company also has granted a 30 days option to its underwriters to purchase up to 1,875,000 shares additional to cover any over allotment.

Celgene Corporation (NASDAQ:CELG) reported the increase of 1.76% and closed at $99.39 with the total traded volume of 6.61 million shares. The stock’s opening price was $97.90. The company has the total of 422.99 million outstanding shares and its total market capitalization is $42.04 billion.

The 52-week price range of the stock remained $58.53 – $99.51, while during last trade its minimum price was $97.22 and it gained its highest price of $99.51. The Company’s last 5 days shows an uptrend with a rise of 21.07%.

Is CELG A Solid Investment At These Levels? Find Out Exactly Where CELG Is Headed With This TREND ANALYSIS REPORT


Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.


Source: anotherwinningtrade Posted Wed, January 16, 2013 15:01 - Permalink